Blue Jet Healthcare, an important player in the pharmaceutical and healthcare ingredients sector, started its Initial Public Offering (IPO) to offer interested investors an opportunity to be part of its growth story. The IPO subscription period started from October 25 and closed on October 27.
Read More: ESAF Small Finance Bank IPO To Open On November 3; All You Need To Know
Blue Jet Healthcare IPO Price Band
Blue Jet Healthcare has set a price band for its IPO, valuing each equity share at a range of Rs 329 to Rs 346, with a face value of Rs 2 per share.
Blue Jet Healthcare IPO Lot Size
To participate in the IPO, investors need to consider the minimum lot size, which is 43 shares. At the lower end of the price band, that is, Rs 329 per share, the minimum investment required to participate in this maiden offering amounts to Rs 14,147.
Blue Jet Healthcare IPO GMP
Blue Jet Healthcare is currently showing a Grey Market Premium (GMP) ranging from Rs 25 to Rs 30, as reported by various market tracking websites.
Read More: Stock Market Updates: Sensex Jumps 200 pts, Nifty Tops 19,200; TaMo Gains 1%
Blue Jet Healthcare IPO Allotment Date
According to the company‘s red herring prospectus, the allotment date for the Blue Jet Healthcare IPO is slated for November 1.
Investors can check the allotment status on the BSE (Bombay Stock Exchange) website.
Follow these steps for checking your allotment :-
–First, visit the official BSE website and select “Equity” as the issue type
–From the issue name dropdown, choose ‘Blue Jet Healthcare.’
–Enter PAN details and complete the bot verification by confirming you are not a robot.
–Clicking “Search” will reveal the allotment status, if available.
Blue Jet Healthcare IPO Listing Date
The company’s shares are set to debut on the bourses on November 6.
Read More: Mamaearth’s parent Honasa Consumer’s IPO to open for subscription today
About Blue Jet Healthcare
Blue Jet Healthcare Limited specialises in pharmaceutical and healthcare ingredients and intermediates. The company’s strategic focus is on developing niche products targeted at both innovator pharmaceutical companies and multinational generic pharmaceutical companies. In the financial year 2023, Blue Jet Healthcare reported robust financial performance, with revenue from operations totaling Rs 720.98 crore and a profit of Rs 160 crore.
